Tagged biomarkerdiscovery

Scailyte Closes Series A Funding With a CHF 6 Million Investment to Develop Strategic Partnerships in Immuno-Oncology
Press Release

Scailyte Closes Series A Funding With a CHF 6 Million Investment to Develop Strategic Partnerships in Immuno-Oncology

 Read More
Nilogen and Scailyte Are Joining Forces to Find the 'Right' Treatment for Every Patient
Press Release

Nilogen and Scailyte Are Joining Forces to Find the 'Right' Treatment for Every Patient

 Read More
Scailyte's 5th Anniversary Mini-Symposium - Machine Learning Meets Multi-Omics for Precision Medicine
Press Release

Scailyte's 5th Anniversary Mini-Symposium - Machine Learning Meets Multi-Omics for Precision Medicine

Bringing industry and academia together to discuss the potential impact of single-cell analytics powered by machine learning for precision medicine.

 Read More
Scailyte AG Announces a Partnership With Sirona DX for AI-Driven End-Point Specific Single-Cell Analysis
Press Release

Scailyte AG Announces a Partnership With Sirona DX for AI-Driven End-Point Specific Single-Cell Analysis

 Read More
Scailyte Hosts Webinar About Supervised Learning of Disease-Associated Cell States and Dynamics
Press Release

Scailyte Hosts Webinar About Supervised Learning of Disease-Associated Cell States and Dynamics

Webinar on the latest developments in the analysis of single-cell data, including from transcriptomic and imaging technologies.

 Read More
Scailyte Closes Financing Round and Onboards Top Biotech Leaders to Prepare for Growth in 2022
Press Release

Scailyte Closes Financing Round and Onboards Top Biotech Leaders to Prepare for Growth in 2022

First closing of Series A round and onboarding of top biotech leaders to fuel growth in 2022

 Read More
Scailyte and Lexogen Create a Joint Biomarker Discovery Workflow for Precision Medicine Companies
Press Release

Scailyte and Lexogen Create a Joint Biomarker Discovery Workflow for Precision Medicine Companies

 Read More
Scailyte Announces Michael Brenner, of Harvard Medical School, as an Advisor to Its Board of Directors
Press Release

Scailyte Announces Michael Brenner, of Harvard Medical School, as an Advisor to Its Board of Directors

 Read More
Scailyte and Geninus Announce a Strategic Partnership to Develop a Predictive Assay for Immune-Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients
Press Release

Scailyte and Geninus Announce a Strategic Partnership to Develop a Predictive Assay for Immune-Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients

 Read More
Scailyte and Volv Global Announce Strategic Partnership to Accelerate Rare Disease Patient Diagnosis
Press Release

Scailyte and Volv Global Announce Strategic Partnership to Accelerate Rare Disease Patient Diagnosis

 Read More